Fortress Biotech
FBIO
48 hedge funds and large institutions have $13.3M invested in Fortress Biotech in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 11 closing their positions.
1,500% more call options, than puts
Call options by funds: $32K | Put options by funds: $2K
0.53% less ownership
Funds ownership: 1.73% → 1.2% (-0.53%)
11% less funds holding
Funds holding: 54 → 48 (-6)
21% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 14
43% less capital invested
Capital invested by funds: $23.4M → $13.3M (-$10.1M)
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
1WM
1900 Wealth Management
San Antonio,
Texas
|
+$183K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$106K |
| 3 |
Corient Private Wealth
Miami,
Florida
|
+$66.4K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$35.1K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JFG
Jefferies Financial Group
New York
|
-$2.34M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$833K |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$348K |
| 4 |
BlackRock
New York
|
-$117K |
| 5 |
Millennium Management
New York
|
-$95K |
FBIO Hedge Fund Activity: Q2 2023 in Review
48 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q2 2023, worth a combined $13.3M — down 43% from $23.4M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of FBIO and 5 opened new positions — a net loss of 6 holders — while 14 trimmed existing stakes and 11 added.
The largest buyer was 1900 Wealth Management, adding an estimated $183K. The largest seller was Jefferies Financial Group, exiting entirely with an estimated $2.34M sold.
- 48 institutional investors held Fortress Biotech (FBIO) as of Q2 2023, down from 54 in Q1 2023.
- Funds reported $13.3M of Fortress Biotech stock for Q2 2023, down 43% quarter-over-quarter.
- 5 funds opened new Fortress Biotech positions in Q2 2023 and 11 closed out, a net change of -6 holders.
- The largest Fortress Biotech buyer in Q2 2023 was 1900 Wealth Management, an estimated $183K added.
- The largest Fortress Biotech seller in Q2 2023 was Jefferies Financial Group, an estimated $2.34M sold.
Based on aggregated 13F filings for Q2 2023.